Literature DB >> 1846470

Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients.

C E Freise1, V Pons, J Lake, E Burke, N L Ascher, J P Roberts.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1846470

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation.

Authors:  I G Sia; J A Wilson; M J Espy; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Cytomegalovirus infection after intestinal transplantation in children.

Authors:  J Bueno; M Green; S Kocoshis; H Furukawa; K Abu-Elmagd; E Yunis; W Irish; S Todo; J Reyes; T E Starzl
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

4.  A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients.

Authors:  M Martin; R Mañez; P Linden; D Estores; J Torre-Cisneros; S Kusne; L Ondick; R Ptachcinski; W Irish; D Kisor
Journal:  Transplantation       Date:  1994-10-15       Impact factor: 4.939

5.  Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies.

Authors:  C Lumbreras; J R Otero; J A Herrero; R Gomez; M Lizasoain; J M Aguado; F Colina; I Garcia; E Moreno; A R Noriega
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.